ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Specialty Chemicals

Ingevity will acquire Perstorp’s caprolactone business

by Michael McCoy
December 16, 2018 | APPEARED IN VOLUME 96, ISSUE 49

 

09649-buscon8-persprcxd.jpg
Credit: Perstorp
Perstorp produces caprolactone at this facility in Warrington, England.

Ingevity has agreed to acquire Perstorp’s caprolactone business for about $675 million. The business produces caprolactone and its derivatives at a plant in Warrington, England. It has annual sales of about $175 million. Ingevity was formed in 2016 as a chemical spin-off of the papermaker MeadWestvaco. Last year Ingevity acquired Georgia-Pacific’s pine chemical business for $315 million.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment